Korean Company Kolmar Develops Targeted Anti-Aging Technology Using Drug Delivery Systems

Kolmar announced on the 10th that it has developed a targeted anti-aging skincare ingredient capable of selectively removing substances causing skin aging, employing principles from targeted cancer therapy. This strategic move signals a significant evolution in the beauty formulation landscape, leveraging pharmaceutical advances to enhance consumer engagement in anti-aging products.

Developed in collaboration with Professor Lee Dong-won’s team at Jeonbuk National University, the antioxidant ingredient 'TOT (Tocopherol-Oxalate-Tocopherol)' has garnered attention by being selected for the cover of the April 2026 issue of the international journal 'Molecules.' This endorsement from a distinguished source underlines the technological credibility and innovation inherent in Kolmar’s approach, positioning the company as a leader in fusion technology within the beauty industry.

The novel TOT ingredient utilizes a dual Vitamin E molecular structure linked by a special agent, Per-Oxalate. When encountered with hydrogen peroxide (H₂O₂), a known aging trigger in the skin, the bonds are released, enabling Vitamin E to exert its antioxidative effects. This targeted release mechanism exemplifies Kolmar's commitment to merging cosmetic formulations with advanced drug delivery systems, enhancing efficacy and consumer trust in product performance.

By implementing its proprietary 'DDS Smart Liposome' technology, Kolmar ensures the stable delivery of TOT to the dermis layer of the skin. This innovation involves encapsulating TOT in micro liposome capsules, allowing for deeper penetration and effective removal of aging substances. The measurable result of a 40% reduction in hydrogen peroxide concentration within 30 minutes further validates the effectiveness of this sophisticated delivery system.

In experimental findings, it was noted that TOT can inhibit cellular damage associated with aging processes at one-tenth the quantity of conventional Vitamin E, indicating a significant improvement in formulation efficacy while potentially lowering costs for manufacturers. This innovation will likely resonate well within the premium skincare segment, offering high-performance options that align with evolving consumer expectations.

Kolmar plans to develop a premium anti-aging skincare line incorporating this technology to penetrate global markets effectively. The integration of pharmaceutical insights into beauty R&D signals an industry shift toward more scientifically driven product offerings, catering to increasing consumer demand for health-focused skincare solutions.

An industry representative stated, “The development of this ingredient culminates in efforts to combat the fundamental causes of aging through a convergence of pharmaceutical and cosmetic technologies.” This progressive approach highlights the importance of R&D in introducing targeted anti-aging products as a sustained strategy moving forward for Kolmar.